SCH 503034 Plus Peg-Intron, With and Without Added Ribavirin, in Patients With Chronic Hepatitis C, Genotype 1, Who Did Not Respond to Previous Treatment With Peginterferon Alfa Plus Ribavirin (Study P03659)(COMPLETED)

This study has been completed.
Information provided by Schering-Plough

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Conditions listed in this trial
			Chronic Hepatitis C
2		Additional conditions recognized in this trial
			Hepatitis
			Hepatitis C
			Hepatitis C, Chronic
			Hepatitis, Chronic
3		More general conditions related to this trial
			Digestive System Diseases
			Flaviviridae Infections
			Hepatitis, Viral, Human
			Liver Diseases
			RNA Virus Infections
			Virus Diseases
4		Interventions listed in this trial
			SCH 503034
5		Additional drug interventions recognized in this trial
			Peginterferon alfa-2b
			Ribavirin
6		More general drug interventions related to this trial
			Anti-Infective Agents
			Antimetabolites
			Antiviral Agents
			Molecular Mechanisms of Pharmacological Action
			Pharmacologic Actions
			Therapeutic Uses
7		Sponsors listed in this trial
			Schering-Plough